References
- Lu X, Shaw CA, Patel A, Li J, Cooper ML, Wells WR, et al. Clinical implementation of chromosomal microarray analysis: summary of 2513 postnatal cases. PLoS One 2007;2:e327. https://doi.org/10.1371/journal.pone.0000327
- Cuoco C, Ronchetto P, Gimelli S, Bena F, Divizia MT, Lerone M, et al. Microarray based analysis of an inherited terminal 3p26.3 deletion, containing only the CHL1 gene, from a normal father to his two affected children. Orphanet J Rare Dis 2011;6:12. https://doi.org/10.1186/1750-1172-6-12
- Fernandez TV, Garcia-Gonzalez IJ, Mason CE, Hernandez-Zaragoza G, Ledezma-Rodriguez VC, Anguiano-Alvarez VM, et al. Molecular characterization of a patient with 3p deletion syndrome and a review of the literature. Am J Med Genet A 2008;146A:2746-52. https://doi.org/10.1002/ajmg.a.32533
- Franco LM, de Ravel T, Graham BH, Frenkel SM, Van Driessche J, Stankiewicz P, et al. A syndrome of short stature, microcephaly and speech delay is associated with duplications reciprocal to the common Sotos syndrome deletion. Eur J Hum Genet 2010;18:258-61. https://doi.org/10.1038/ejhg.2009.164
- Dikow N, Maas B, Gaspar H, Kreiss-Nachtsheim M, Engels H, Kuechler A, et al. The phenotypic spectrum of duplication 5q35.2-q35.3 encompassing NSD1: is it really a reversed Sotos syndrome? Am J Med Genet A 2013;161A:2158-66.
- Orphanet. Prevalence and incidence of rare diseases: bibliographic data - diseases listed by decreasing prevalence, incidence or number of published cases. [http://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_decreasing_prevalence_or_ cases.pdf]
- Lee HJ, Kim JH, Cho JH, Lee BH, Choi JH, Yoo HW. Clinical characterization of a Korean case with 3p25 deletion. J Genet Med 2014;11:36-9. https://doi.org/10.5734/JGM.2014.11.1.36
- Park S, Lee GW, Koh EH, Kim HY. Unexplained pancytopenia in a patient with 5q35.2-q35.3 microduplication encompassing NSD1: a case report. Int J Hematol Oncol Stem Cell Res 2018;12:260-4.
- Shaffer LG, Kashork CD, Saleki R, Rorem E, Sundin K, Ballif BC, et al. Targeted genomic microarray analysis for identification of chromosome abnormalities in 1500 consecutive clinical cases. J Pediatr 2006;149:98-102. https://doi.org/10.1016/j.jpeds.2006.02.006
- Schoumans J, Ruivenkamp C, Holmberg E, Kyllerman M, Anderlid BM, Nordenskjold M. Detection of chromosomal imbalances in children with idiopathic mental retardation by array based comparative genomic hybridisation (array-CGH). J Med Genet 2005;42:699-705. https://doi.org/10.1136/jmg.2004.029637
- Tyson C, Harvard C, Locker R, Friedman JM, Langlois S, Lewis ME, et al. Submicroscopic deletions and duplications in individuals with intellectual disability detected by array-CGH. Am J Med Genet A 2005;139:173-85.
- Jehee FS, Takamori JT, Medeiros PF, Pordeus AC, Latini FR, Bertola DR, et al. Using a combination of MLPA kits to detect chromosomal imbalances in patients with multiple congenital anomalies and mental retardation is a valuable choice for developing countries. Eur J Med Genet 2011;54:e425-32. https://doi.org/10.1016/j.ejmg.2011.03.007
- Coulter ME, Miller DT, Harris DJ, Hawley P, Picker J, Roberts AE, et al. Chromosomal microarray testing influences medical management. Genet Med 2011;13:770-6. https://doi.org/10.1097/GIM.0b013e31821dd54a
- Stankiewicz P, Beaudet AL. Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation. Curr Opin Genet Dev 2007;17:182-92. https://doi.org/10.1016/j.gde.2007.04.009
- Jiang J, Gill BS, Wang GL, Ronald PC, Ward DC. Metaphase and interphase fluorescence in situ hybridization mapping of the rice genome with bacterial artificial chromosomes. Proc Natl Acad Sci U S A 1995;92:4487-91. https://doi.org/10.1073/pnas.92.10.4487
- Pinkel D, Landegent J, Collins C, Fuscoe J, Segraves R, Lucas J, et al. Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. Proc Natl Acad Sci U S A 1988;85:9138-42. https://doi.org/10.1073/pnas.85.23.9138